Predictive Value of Pretreatment BCR-ABL(IS) Transcript level on Response to Imatinib Therapy in Egyptian Patients with Chronic Phase Chronic Myeloid Leukemia (CPCML)

BACKGROUND: A wide range of responses of patients with CPCML to IM has been reported. Several factors were proposed to predict response including molecular response at 3 and 6 months. Purpose: To study the impact of pretreatment BCR-ABL transcript level on molecular response to IM, and to assess the...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: El-Metnawy, Wafaa H., Mattar, Mervat M., El-Nahass, Yasser H., Samra, Mohamed A., Abdelhamid, Hala M., AbdlFattah, Raafat M., Hamed, Ahmad R.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Master Publishing Group 2013
Ämnen:
Original Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3644415/
https://ncbi.nlm.nih.gov/pubmed/23675289
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk